Bacterial meningitis is rare in the United States, but it remains one of the most dangerous infections a person can get. Across all bacterial causes combined, roughly 3,000 to 4,000 cases occur each year in a country of over 330 million people. That translates to about 1 case per 100,000 people annually, making your individual risk in any given year extremely low. The rarity, however, can be misleading: bacterial meningitis kills about 1 in 6 people who develop it and leaves 1 in 5 survivors with lasting complications.
How the Numbers Break Down
Five bacteria cause nearly all cases of bacterial meningitis in the U.S. The most common, by a wide margin, is the pneumococcal bacterium, responsible for about 58% of cases. Group B strep accounts for roughly 21%, followed by a type of influenza bacterium at 11%, the meningococcal bacterium at about 7%, and listeria at 3%. These proportions come from 15 years of active surveillance data covering 2008 through 2023.
When people hear “meningitis outbreak,” they’re usually thinking of meningococcal disease, the type most associated with college campuses and news headlines. But meningococcal meningitis is actually the least common major type. In 2024, just 503 confirmed and probable meningococcal cases were reported nationwide. That’s a sharp increase from pandemic-era lows, and it now exceeds pre-pandemic levels, but it’s still far below the rates seen in the 1990s.
Who Faces the Highest Risk
Age is the single biggest risk factor. Newborns under two months old have the highest incidence of any age group, and their cases look different from everyone else’s. Group B strep causes 85% of bacterial meningitis in that age window, largely because the bacterium can pass from mother to baby during delivery.
College freshmen living in dormitories face a modestly elevated risk for meningococcal disease specifically. CDC data shows cases occurred 9 to 23 times more frequently among dorm residents than among students in other living arrangements. The rate for freshmen in dorms was about 4.6 per 100,000, higher than nearly every other age group except infants. Still, college students overall actually get meningococcal disease at a lower rate (0.7 per 100,000) than same-age peers not enrolled in college (1.5 per 100,000). Dorm living concentrates the risk among a subset of students.
Other groups with increased vulnerability include people without a functioning spleen, those with weakened immune systems, and people with certain complement deficiencies (a part of the immune system that helps fight bacteria).
Rare Here, Common Elsewhere
What counts as “rare” depends on geography. In sub-Saharan Africa’s meningitis belt, a stretch of countries from Senegal to Ethiopia, the disease is a recurring public health crisis. Incidence rates there range from about 42 per 100,000 in northern subregions to nearly 112 per 100,000 in western subregions. That’s roughly 100 times the U.S. rate. Seasonal epidemics sweep through during dry months, and a single outbreak can produce thousands of cases in weeks.
Widespread vaccination is the main reason bacterial meningitis is so uncommon in the U.S. and other high-income countries. Vaccines against the pneumococcal bacterium, the meningococcal bacterium, and the influenza-type bacterium have collectively driven rates down over several decades. The sharpest decline came after routine childhood vaccines were introduced in the 1990s and 2000s.
Why Rarity Doesn’t Mean Low Stakes
Bacterial meningitis can progress from first symptoms to death in a matter of hours. That speed is part of what makes it so dangerous despite being uncommon. Early symptoms often look like a bad flu: fever, headache, stiff neck. In infants, the signs can be even less obvious, sometimes just irritability, poor feeding, or a bulging soft spot on the head.
Among those who survive, about 20% face lasting complications. These range from hearing loss and seizures to limb weakness, vision problems, and difficulties with memory and communication. Some survivors of meningitis-related blood infections require limb amputations. The severity of these outcomes is a major reason public health authorities treat even small clusters of cases as urgent.
Putting Your Risk in Perspective
For a healthy adult in the U.S. who is up to date on vaccinations, the chance of developing bacterial meningitis in any given year is very small. You’re far more likely to be hospitalized for the flu or a car accident. But the combination of rapid progression, high fatality, and serious long-term damage means bacterial meningitis punches well above its weight in terms of consequences. It’s the kind of rare event where prevention (vaccination, awareness of early symptoms) matters enormously, because once it starts, the window to intervene is narrow.